The agreement includes the Medidata Platform, Medidata Adjudicate and other Medidata Rave products to support PPD’s clinical research business in advancing customers’ drug development programs.
A key element of this relationship is the development of PPD TrueCast, a commercial solution powered by Medidata AI designed to shorten studies by combining patient recruitment and site performance data to deliver powerful predictive models and advanced analytics time.
“Over the past 15 years, we have developed valuable relationships with PPD’s clinical research business to improve visibility and decision-making during clinical trials,” said Janet Butler, executive vice president and global head of sales at Medidata. “We look forward to working together to Complete research faster, improve drug development efficiency, and ultimately bring life-changing treatments to patients faster.”
Medidata has partnered with PPD’s clinical research business since 2009 to conduct more than 1,000 clinical studies for biopharmaceutical and medical device companies across a broad range of therapeutic areas from oncology to vaccines.
More Medidata news
Earlier this month, Medidata and Sanofi Vaccines announced a collaboration to leverage Medidata’s Electronic Clinical Outcomes Assessment (eCOA) for deployment in vaccine studies.
